Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.22.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Common Stock Subscribed But Not Issued [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Noncontrolling Interest [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 314,000 $ 5,000 $ 112,974,000 $ (104,615,000) $ (577,000) $ 8,101,000
Beginning Balance, shares at Dec. 31, 2020 314,418,812 11,413        
Issuance of subscribed shares $ (5,000) 5,000
Issuance of subscribed shares, shares 11,413 (11,413)        
Stock grants $ 5,000 5,000
Stock grants, shares   6,877        
Exercise of warrants 8,000 8,000
Exercise of Warrants Shares 50,000          
Amortization of option grants 295,000 295,000
Issuance of stand-alone warrants 56,000 56,000
Conversion of debentures payable $ 5,000 1,351,000 1,356,000
Conversion of debentures payable, shares 4,610,645          
Conversion of promissory notes $ 3,000 1,007,000 1,010,000
Conversion of promissory notes, shares 3,365,972          
Common stock issued to settle obligations 31,000 31,000
Common stock issued to settle obligations, shares 42,857          
Equity issuance costs (387,000) (387,000)
Distributions (83,000) (83,000)
Net income 4,220,000 90,000 4,310,000
Ending balance, value at Mar. 31, 2021 $ 322,000 $ 5,000 115,340,000 (100,395,000) (570,000) 14,702,000
Ending Balance, shares at Mar. 31, 2021 322,499,699 6,877        
Beginning balance, value at Dec. 31, 2021 $ 334,000 134,920,000 (97,392,000) (1,563,000) 36,299,000
Beginning Balance, shares at Dec. 31, 2021 334,030,348        
Stock grants $ 2,000 2,000
Stock grants, shares   2,717        
Amortization of option grants 2,469,000 2,469,000
Conversion of promissory notes $ 1,000 399,000 400,000
Conversion of promissory notes, shares 1,142,858          
Distributions (101,000) (101,000)
Net income 4,188,000 53,000 4,241,000
Exercise of options 3,000 3,000
Exercise of options, shares 10,000          
Fees paid with stock $ 1,000 273,000 274,000
Fees paid with stock, shares 375,000          
Ending balance, value at Mar. 31, 2022 $ 336,000 $ 2,000 $ 138,064,000 $ (93,204,000) $ (1,611,000) $ 43,587,000
Ending Balance, shares at Mar. 31, 2022 335,558,206 2,717